ADB, HSBC unveil $300m COVID-19 vaccine financing

HSBC and the Asian Development Bank have announced a $300 million financing programme to help the region’s supply chains scale-up to deliver vaccines at both volume and pace.

The targeted financing will inject liquidity into the vaccine ecosystem – from sourcing and manufacturing through to distribution. It will support the ecosystem’s long- term reconfiguration to deliver mass COVID-19 inoculation.

The public private partnership extends an innovative risk-sharing agreement between HSBC and ADB launched in July 2020 to support PPE suppliers. By leveraging the ADB’s sovereign rating, the programme enables greater private sector participation than would otherwise be possible leading to higher levels of liquidity.